Home › Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment
 

Keywords :   


Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment

2015-07-18 19:52:36| Biotech - Topix.net

Geron and partner Johnson & Johnson missed their self-imposed target date for the start of trial enrollment, yet Geron's stock hit its 52-week high post the deadline. I am speculating the delay may be driven by JNJ laying the groundwork for a possible Breakthrough Drug Therapy designation for Imetelstat.

Tags: study locations phase begins

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 3
29.06Tropical Storm Beryl Public Advisory Number 3
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 3
29.06Tropical Storm Beryl Forecast Advisory Number 3
29.06Eastern North Pacific Tropical Weather Outlook
29.06Atlantic Tropical Weather Outlook
More »